
Clinician-scientist in genetics & mental health, researching genetic tools for guiding prescription meds in psychiatry. Lead of IMPACT study. #pharmacogenetics
Toronto, Ontario
Joined April 2019
- Tweets167
- Following52
- Followers311
- Likes116
Well done Ana! Terrific learning opportunity!
This Post is from an account that no longer exists. Learn more
6
351
Excellent addition to the growing datasets for pharmacogenomis in psychiaty!
Our newest paper is out in @molpsychiatry! Great job, team!
nature.com/articles/s41380-0…
8
286
Jim Kennedy retweeted
A CAMH, @UofT and @ICESOntario study published in the @CambUP_Psych journal found that teens who use #cannabis are 11x more likely to develop a psychotic disorder, demonstrating a link between self-reported cannabis use and psychotic disorders.
⬇️MORE:
camh.ca/en/camh-news-and-sto…
Jim Kennedy retweeted
A joint study between CAMH, @UofT and @ICESOntario study found that teens who used #cannabis had a dramatically higher rate of developing a psychotic disorder.
Teenagers who use cannabis are more likely to suffer psychotic disorders than those who do not, a study finds. nbcnews.com/health/health-ne…
Replying to @AfterHoursDavid @CP24
@TPSOperations just reported a large fire at Cherry and Unwin Streets…drives me crazy not getting instant news from Twitter anymore. Used to be we’d get info all the time, lots of pics, etc.
this is big enough that someone I know north of the Danforth can smell the smoke
I just returned from Harry Rosen’s funeral. He lived a full life of dedication to others including special attention to mental health and supporting CAMH. The quote on his office wall points out that each individual is unique — also true for mental health care.
Our group is presenting their work in #WCPG2023 ! Check out posters 5, 38,43, and 89. Happening now!
Jim Kennedy retweeted
#FactFriday Did you know that Canada has the lowest spending on research and development among the #G7, with no increase in the last 20 years?
#Canada is falling behind in research and development and it's time we catch up 🕐
Jim Kennedy retweeted
Doubtful most Canadians are aware of how little we invest in R&D as a nation. This table is highlighted to show how little Australia invests. Canada is even lower on this list.
This is the league table of how countries are currently investing in R&D as a % of GDP. The figures continue a 14-year⬇️trend in national R&D investment for Australia. If we keep going the way we are, in 5yrs years we'll be among the lowest of all @OECD countries #Auspol2023
Very impressive Tanenbaum Centre @CAMHResearch group! Also note DNA AND NAD wherein the latter is Nicotinamide Adenine Dinucleotide, a key component of mitochondrial energy production.
Our latest lab group pictures:
Turning DNA into DAN(iel)... 😂
#PGxRC
Jim Kennedy retweeted
I have been very lucky to attend the 64th #McKusickShortCourse on Human and Mammalian Genetics and Genomics.
I am learning so much and have met a lot of bright and inspiring researchers in genetics 🧬
Jim Kennedy retweeted
We’re pleased to welcome Christine Elliott (@celliottability) to our Board of Trustees!
Christine was the Minister of Health + Deputy Premier of #Ontario until 2022 and has significant knowledge of, and experience with the health system. She also co-founded the @AbilitiesCentre
Jim Kennedy retweeted
Commentary in @TheLancet by @dvoineskosmd and Daniel Blumberger, clinician-scientists @camhnews on #TDCS as a treatment for major depressive disorder. #depression #neurostimulation.
thelancet.com/journals/lance…
Jim Kennedy retweeted
A groundbreaking new CAMH study published in @JAMAPsych led by Scientist Dr. Jeffrey Meyer found that people who experienced long #COVID had elevated levels of brain inflammation – raising the possibility of new #treatments.
MORE:
camh.ca/en/camh-news-and-sto…
Jim Kennedy retweeted
It's an honour to receive @theCINP Max Hamilton Memorial Prize at @cinp2023. Grateful to mentors, colleagues, family, and friends to support!
Very proud to see CAMH/Univ of Toronto scientist Dr Clement Zai receive the Hamilton Prize at #CINP2023 in Montreal. Among many discoveries, he detailed the role of DRD2 gene in #schizophrenia in 2007 and the VMAT2 target for the TD drug valbenazine in 2012
Here is my example of trying to explain fairly complicated neurotransmitter measurement in non-jargon layperson terms.
Replying to @CAMHnews
(2/2)
People may want to measure their serotonin and dopamine levels for a variety of reasons, including investigating medical conditions or monitoring treatment.
Dr. James Kennedy joined us to explain the different ways available to measure these chemicals in someone’s body.
Very pleased to have our #pharmacogenetics and #precisionmedicine research in #mentalhealth described in @IMSMagazine. There are many unmet needs to be addressed in the challenges facing improved care for #mentalillness.
Imagine if we had Google for our genes! Dr. James Kennedy discusses his research on pharmacogenetic testing and mental health research.
imsmagazine.com/2023/02/05/f…
@mahbooli99 @JimKennedyMD
#pharmacogenetics, #Schizophrenia , @CAMHnews, @CAMHResearch
: Xinyi Li (Insta: @xinyilivis)
Great to see Dr Aristotle Voineskos on CTV News this morning re @camhnews @camhresearch mental health research, 1000 research staff, new discoveries, team science, and campaign by @camhfoundation to build a new home for our lifesaving research!





























